Michael Beitman
About Michael Beitman
Michael Beitman is a Vice President at Piper Sandler, where he has worked since 2019. He has a background in finance with experience at various firms, including Wells Fargo Advisors and Autonomous Therapeutics, and holds an MBA from NYU Stern School of Business.
Current Role at Piper Sandler
Michael Beitman serves as Vice President at Piper Sandler, a position he has held since 2019. He works in the San Francisco Bay Area, where he contributes to the firm's strategic initiatives and client services. His role involves overseeing various financial operations and providing insights to enhance the firm's offerings.
Previous Experience in Financial Services
Before joining Piper Sandler, Beitman held several positions in the financial services sector. He worked at Wells Fargo Advisors as a Financial Consultant in Services & Operations from 2013 to 2017, and previously served in various roles, including Financial Consultant in the Decision Support Group and as a Summer Analyst in the Financial Products Group. His experience spans multiple facets of financial consulting and operations.
Educational Background
Michael Beitman earned his Master of Business Administration (MBA) from NYU Stern School of Business, where he focused on Finance from 2017 to 2019. Prior to that, he studied at Washington University in St. Louis - Olin Business School from 2008 to 2012, completing a four-year program. His educational background provides a strong foundation for his career in finance.
Internships and Early Career
Beitman's early career includes several internships that provided him with valuable experience in finance. He interned at Smith Barney for three months in 2009 and worked as a Summer Analyst at Hotchkis and Wiley Capital Management in 2011. Additionally, he served as an Investment Banking Summer Associate at Piper Jaffray in 2018, gaining insights into investment banking practices.
Venture Associate Role
From 2018 to 2019, Michael Beitman worked as an MBA Venture Associate at Autonomous Therapeutics, Inc. during a six-month tenure. In this role, he focused on venture capital initiatives and supported the firm's strategic investments, further broadening his expertise in the financial sector.